Cargando…

Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery

Detalles Bibliográficos
Autores principales:	Hashemzadeh, Mohammad Sadegh, Gharari, Nariman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070569/ https://www.ncbi.nlm.nih.gov/pubmed/37010668 http://dx.doi.org/10.1186/s43141-023-00485-x

Ejemplares similares

Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery
por: Hashemzadeh, Mohammad Sadegh, et al.
Publicado: (2023)

Correction: Telomere and subtelomere high polymorphism might contribute to the specifcity of homologous recognition and pairing during meiosis in barley in the context of breeding
por: Serrano-León, I. M., et al.
Publicado: (2023)

Specifcations d'un dispositif de mesures optiques
por: Lohmann, KD
Publicado: (1969)

To Bev or Not to Bev during Ovarian Cancer Maintenance Therapy?
por: Sznurkowski, Jacek Jan
Publicado: (2023)

Correction: Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs
por: Liu, Wei, et al.
Publicado: (2022)

Targeted Delivery of Protein Drugs by Nanocarriers
por: Solaro, Roberto, et al.
Publicado: (2010)

Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
por: Pirola, Carlos J., et al.
Publicado: (2022)

Comments on machines for the energy range 2-BeV to 10-Bev
por: Midwestern Univ. Res. Ass.
Publicado: (1954)

Implications of biomimetic nanocarriers in targeted drug delivery
por: Al-Hetty, Hussein Riyadh Abdul Kareem, et al.
Publicado: (2023)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

GeV or BeV?
Publicado: (1960)

Correction to: Boron nitride nanotubes as containers for targeted drug delivery of doxorubicin
por: Nejad, Marjan A., et al.
Publicado: (2021)

Correction to: Boron nitride nanotubes as containers for targeted drug delivery of doxorubicin
por: Nejad, Marjan A., et al.
Publicado: (2022)

GeV ou BeV ?
Publicado: (1960)

Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery
por: Marques, Joana, et al.
Publicado: (2017)

Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems
por: Hejabi, Faranak, et al.
Publicado: (2022)

Correction: Nano-immunotherapy: overcoming delivery challenge of immune checkpoint therapy
por: Kiaie, Seyed Hossein, et al.
Publicado: (2023)

Synthesis and characterization of amine-functionalized Fe(3)O(4)/Mesoporous Silica Nanoparticles (MSNs) as potential nanocarriers in drug delivery systems
por: Tabasi, Hamed, et al.
Publicado: (2022)

Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specifc cell-permeable peptide inhibitor
por: Martins, Leila R., et al.
Publicado: (2013)

Genetically engineered nanocarriers for drug delivery
por: Shi, Pu, et al.
Publicado: (2014)

Raman Imaging of Nanocarriers for Drug Delivery
por: Vanden-Hehir, Sally, et al.
Publicado: (2019)

Multifunctional Nanocarriers for Lung Drug Delivery
por: Pontes, Jorge F., et al.
Publicado: (2020)

A detailed insight of the tumor targeting using nanocarrier drug delivery system
por: Batool, Sibgha, et al.
Publicado: (2023)

MIL-125-based nanocarrier decorated with Palladium complex for targeted drug delivery
por: Bagherzadeh, Mojtaba, et al.
Publicado: (2022)

Correction: Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047
por: Murray-Stewart, Tracy, et al.
Publicado: (2017)

Polyester dendrimers: a versatile nanocarrier for target specific drug delivery
por: Aravind, A, et al.
Publicado: (2012)

Stimuli-Responsive Aliphatic Polycarbonate Nanocarriers for Tumor-Targeted Drug Delivery
por: Domiński, Adrian, et al.
Publicado: (2020)

Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy
por: Xia, Wentao, et al.
Publicado: (2021)

Fluorescent liposomal nanocarriers for targeted drug delivery in ischemic stroke therapy
por: Arul, Michael R., et al.
Publicado: (2023)

Particles produced by 24 BeV protons
por: Gilly, L, et al.
Publicado: (1960)

Multi-BeV linear electron accelerators
por: Vickers Group Research Establishment. Weybridge
Publicado: (1957)

200 BeV accelerator design study
por: University of California. Berkeley. Radiation Laboratory
Publicado: (1965)

200 BeV accelerator design study
por: University of California. Berkeley. Radiation Laboratory
Publicado: (1965)

200 BeV accelerator design study
por: University of California. Berkeley. Radiation Laboratory
Publicado: (1965)

Magnetic characteristics of the 10 Bev proton synchrotron
por: Zhuravlev, A A, et al.
Publicado: (1956)

Vacuum chamber of the 10 Bev synchrotron electromagnet
por: Komar, E G, et al.
Publicado: (1956)

Nanogels as novel drug nanocarriers for CNS drug delivery
por: Manimaran, V., et al.
Publicado: (2023)

Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery
por: Sánchez-Sánchez, Lorena, et al.
Publicado: (2015)

Correction to “Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier”
por: Lu, Jianqin, et al.
Publicado: (2019)

Organic materials as smart nanocarriers for drug delivery
por: Grumezescu, Alexandru Mihai
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4q6jljfo8t2brq0h0k1tf5annb